BMS 214778,
BMS-214778,
BMS214778,
N-((2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)propanamide,
tasimelteon,
Tasimelteon,
609799-22-6,
Hetlioz,
VEC-162,
BMS-214778,
VEC 162,
BMS 214778,
UNII-SHS4PU80D9,
SHS4PU80D9,
CHEBI:79042,
N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide,
Tasimelteon [USAN:INN],
tasimelteonum,
N-(((1R,2R)-2-(2,3-Dihydro-1-benzofuran-4-yl)cyclopropyl)methyl)propanamide,
N-([(1r,2r)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl)propanamide,
N-[[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamide,
Hetlioz (TN),
Tasimelteon (USAN/INN),
GTPL7393,
SCHEMBL3505912,
CHEMBL2103822,
N-(((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide,
Tasimelteon, >=98% (HPLC),
DTXSID70209826,
PTOIAAWZLUQTIO-GXFFZTMASA-N,
ACT06729,
BCP07180,
EX-A2729,
ZINC4392649,
MFCD09033789,
AKOS025149360,
AC-6143,
CS-5512,
DB09071,
SB16782,
KS-0000063S,
AK188029,
AN-10364,
AS-35291,
HY-14803,
X5820,
J3.640.465E,
D09388,
799T226,
(trans)-N-[[2-(2,3-dihydrobenzofuran-4-yl) cyclopropyl]methyl]propanamide,
(trans)-N-[[2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl]methyl]propanamide,
N-[[(1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl]methyl]propanamide,
(-)-(trans)-N-[[2-(2,3-Dihydrobenzofuran-4-yl)cycloprop-1-yl] methyl]propanamide,
Propanamide, N-(((1R,2R)-2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)-,
Tasimelteon [USAN],
D0Q5MQ,
MA 1,
MA-1,
C15H19NO2,
CID10220503,
N-[[(1R,2R)-2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide,
N-[[(1S,2S)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl]methyl]propanamide,
(1R-trans)-N-[[2-(2,3-dihydrobenzofuran-4-yl)cycloprop-1-yl]methyl]propanamide,